Is GLP-1 Nose Something You Need to Be Concerned About Now?

# Is GLP-1 Nose Something You Need to Be Concerned About Now?

GLP-1 receptor agonists like semaglutide and tirzepatide have transformed weight loss treatment, but recent reports of facial sagging and skin changes have sparked concern among patients and dermatologists. The phenomenon, dubbed "GLP-1 nose" or more accurately "GLP-1 face," reflects how rapid weight loss from these medications affects facial structure.

Here's what happens. When someone loses significant weight quickly, the face loses volume beneath the skin. Fat deposits that once supported cheeks, chin, and nose gradually disappear. This process typically takes months to years with conventional dieting, but GLP-1 drugs accelerate it dramatically. The skin doesn't always adjust at the same pace as the underlying tissue shrinks, sometimes creating a hollow or aged appearance.

Dermatologists emphasize that this is not a medication side effect per se, but rather a visible consequence of rapid fat loss. Dr. Joshua Zeichner, director of cosmetic and clinical research in dermatology at Mount Sinai Hospital, notes that the speed of weight loss matters. Patients losing pounds over weeks or months see more pronounced facial changes than those who lose weight gradually over years.

The concern intensifies for older patients. As skin ages, it loses collagen and elastin naturally. Combined with rapid volume loss from GLP-1 use, this can create a more dramatic aging effect. Younger patients with better skin elasticity often bounce back more effectively.

Doctors recommend discussing facial changes before starting GLP-1 treatment, especially for those already concerned about aging skin. Some practitioners suggest dermatological interventions like fillers or skin-tightening procedures alongside weight loss. Others advise patience, since some volume redistribution naturally occurs as the body stabilizes at a new weight.